Clearbridge Health (SGX:1H3) Debt-to-Equity : 0.75 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health Debt-to-Equity?

Clearbridge Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was S$2.04 Mil. Clearbridge Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was S$5.60 Mil. Clearbridge Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was S$10.19 Mil. Clearbridge Health's debt to equity for the quarter that ended in Dec. 2023 was 0.75.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Clearbridge Health's Debt-to-Equity or its related term are showing as below:

SGX:1H3' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.21 Max: 0.75
Current: 0.75

During the past 10 years, the highest Debt-to-Equity Ratio of Clearbridge Health was 0.75. The lowest was 0.02. And the median was 0.21.

SGX:1H3's Debt-to-Equity is ranked worse than
78.87% of 194 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs SGX:1H3: 0.75

Clearbridge Health Debt-to-Equity Historical Data

The historical data trend for Clearbridge Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health Debt-to-Equity Chart

Clearbridge Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.47

0.34

0.24

0.18

0.75

Clearbridge Health Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial													0.24	0.22	0.18	0.17	0.75

Competitive Comparison of Clearbridge Health's Debt-to-Equity

For the Diagnostics & Research subindustry, Clearbridge Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearbridge Health's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's Debt-to-Equity falls into.

Clearbridge Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Clearbridge Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.037	+	5.599)	/	10.19
	=	0.75

Clearbridge Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.037	+	5.599)	/	10.19
	=	0.75

Clearbridge Health (SGX:1H3) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Clearbridge Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (SGX:1H3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177

Website

https://www.clearbridgehealth.com

Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines